[
  {
    "page_idx": 0,
    "text": "as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.\n\nName of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group, Lung Injury, Repair, and Remodeling Study Section.\n\nDate: February 25–26, 2019.\n\nTime: 8:00 a.m. to 5:00 p.m.\n\nAgenda: To review and evaluate grant applications.\n\nPlace: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW, Washington, DC 20015.\n\nContact Person: Ghenima Dirami, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockefeller Drive, Room 4122, MSC 7814, Bethesda, MD 20892, 240–498–7546, dirami@csr.nih.gov.\n\n(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS)\n\nDated: January 30, 2019.\n\nMelanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy.\n\n[FR Doc. 2019–01001 Filed 2–4–19; 8:45 am]\n\nBilling Code 4140–41–P\n\nDEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nNational Institutes of Health\n\nCenter For Scientific Review; Notice of Closed Meeting\n\nPursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.\n\nThe meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patent able material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute an unwarranted invasion of personal privacy.\n\nName of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group, Neural Oxidative Metabolism and Death Study Section.\n\nDate: February 25–26, 2019.\n\nTime: 8.00 a.m. to 4:00 p.m.\n\nAgenda: To review and evaluate grant applications.\n\nPlace: Hotel Zoe Fisherman’s Wharf, 425 North Point, San Francisco, CA 94133.\n\nContact Person: Carol Hamelink, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 5701 Rockefeller Drive, Room 4192, MSC 7850, Bethesda, MD 20892, 3011 213–9887, hamelinc@csr.nih.gov.\n\n(Catalogue of Federal Domestic Assistance Program Nos. 93.306), Comparative Medicine; 93.333, Clinical Research, 93.306, 93.336, 93.337, 93.393–93.396, 93.837-93.844, 93.846–93.878, 93.892, 93893, National Institutes of Health, HHS).\n\nDated: January 30, 2019.\n\nMelanie J. Pantoja, National Institutes of Health, Program Analyst, Office of Federal Advisory Committee Policy.\n\n[FR Doc. 2019–00108 Filed 2–4–19; 8:45 am]\n\nBilling Code 4141–41–P\n\nDEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nNational Institutes of Health\n\nNational Institute of Health\n\nNational Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting\n\nPursuant to section 10(d) of the Federal Advisory Council, as amended, notice is hereby given of the following meeting.\n\nThe meeting will be closed to Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.\n\nThe meeting is hereby given of the following meeting.\n\nThe meeting will be closed to the public in accordance with section 552b(c)(4) and 552b(c)(6), Title 5 U. S. C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such a patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which should constitute an unwarranted invasion of personal privacy.\n\nName of Committee: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, HHS.\n\nDate: February 28, 2019.\n\nTime: 1:00 p.m. to 3:30 p.m.\n\nAgenda: To review and evaluate grant applications.\n\nPlace: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).\n\nContact Person: Jason D. Hoffert, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, 301–496–9010, hoffertj@niddk.nih.gov.\n\n(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)\n\nDated: January 30, 2019. \n\nMelanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy.\n\n[ FR Doc. 2019–01008 Filed 2–4–19; 8:45 am]\n\nBilling Code 4410–41–P\n\nDEPARTMENT OF HEALTH AND HUMAN SERVICES\n\nNational Institutes of Health\n\nNational Heart, Lung, and Blood Institute; Notice of Meeting\n\nPursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.\n\nThe meeting will be closed to the public in accord ance with the section 552b(c)(4) and 552b(c)(6), Title 5. U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commer cial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclo sure of which would constitute a clearly unwarranted invasion of personal privacy.\n\nName of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, CLTR and R61 Conflict Meeting (UG3 and U24).\n\nDate: March 1, 2019.\n\nTime: 8:30 a.m. to 6:00 p.m.\n\nAgenda: To review and evaluate grant applications.\n\nPlace: The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854.\n\nContact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockefeller Drive, Room 7184, Bethesda, MD 20892, 301–827–7942, lismerin@nhlbi.nih.gov.\n\n(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)\n\nDated: January 30, 2018.\n\nRonald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy.\n\n[FR Doc. 2019–01011 Filed 2–4–19; 8:45 am]\n\nBilling Code 4411–41–P"
  }
]